HollandBIO welcomes Leyden Labs

HollandBIO connects, represents and supports the Dutch life science sector. We are very proud that we already represent over 240 companies: from start-ups, small and medium-sized companies to large companies, active in health, food or biobased economy. Today we welcome Leyden Labs! Leyden Labs likes to address a word to the reader:

The outbreak of COVID-19 caught the world off guard and severely constrained people’s ability to live their lives to the fullest. Responses have been very broad (such as social distancing) or targeting specific strains (such as vaccines). And while crucial and developed at unprecedented speed, all responses are reactive.

What the world needs is a proactive approach. Nature harbors millions of unknown viruses and with virus mutations in humans, new infections are a given. However, we don’t know which one will strike next. The current reactive approach does not prepare us for these future threats. At Leyden Labs, we enable this by developing our platform and products with three innovative concepts: By targeting the commonalities of these families, we can develop protection against entire virus families at once, including the unknown variants. Our focus is on respiratory viruses like influenza and coronaviruses, which are most likely to cause pandemics because they are transmitted through the air. Through our platform, we are developing nasal sprays that provide immediate protection because they attack viruses where they attack us – in our nasal passages – keeping people safe from catching infections and preventing people from spreading them to others.

We are working toward accessible, self-administrable products, so people can take control and live their lives to the fullest by protecting themselves against catching infections and preventing transmission to others.